Overview: Pancreatic Elastase (Fecal Elastase) TestIntroduction: The Pancreatic Elastase (Fecal Elastase) Test measures pancreatic elastase in stool to assess pancreatic function, linked to digestive issues or weight loss. Aligned with 2023 ACG guidelines, it uses an immunoassay for high sensitivity, aiding in digestive screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in immunology for patients with suspected pancreatic disorders.
Other Names: Fecal Elastase Assay, Pancreatic Function Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Fecal elastase testing began in the 1990s with pancreatic research. Immunoassays emerged in the 2000s, improving accuracy for pancreatic function assessment.
Purpose: Diagnoses pancreatic disorders, guides treatment, and monitors elastase levels in patients with digestive issues or weight loss.
Test Parameters: 1. Pancreatic Elastase
Pretest Condition: Fasting for 10-12 hours required to stabilize results. Collect stool at any time. Report symptoms like digestive issues or weight loss, and list medications like pancreatic enzymes.
Specimen: 5-10 g stool (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document digestive issues, weight loss, or history of pancreatic disorders (e.g., chronic pancreatitis, cystic fibrosis). Include current medications, especially pancreatic enzymes.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for pancreatic therapy.
Procedural Considerations: Uses an immunoassay to measure fecal pancreatic elastase levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, contamination, or medications can affect results. Non-pancreatic diarrhea may lower levels.
Clinical Significance: Low elastase levels suggest pancreatic insufficiency, prompting enzyme replacement therapy. Normal levels may require further testing.
Specialist Consultation: Consult a gastroenterologist for result interpretation.
Additional Supporting Tests: Pancreatic function tests, imaging (e.g., CT), or amylase/lipase levels to confirm pancreatic disorders.
Test Limitations: Non-specific reductions may occur in non-pancreatic conditions. Results require clinical correlation.
References: ACG Pancreatic Guidelines, 2023; Gastroenterology, Whitcomb DC, 2022.
